rdf:type |
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0025598,
umls-concept:C0030705,
umls-concept:C0061323,
umls-concept:C0071097,
umls-concept:C0311400,
umls-concept:C0439234,
umls-concept:C1280500,
umls-concept:C1518321,
umls-concept:C1556094,
umls-concept:C1707455
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-7-19
|
pubmed:abstractText |
To compare the metabolic effects of pioglitazone, metformin, and glimepiride in the treatment of Japanese patients with newly diagnosed Type 2 diabetes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/glimepiride,
http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0742-3071
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
980-5
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16026361-Aged,
pubmed-meshheading:16026361-Asian Continental Ancestry Group,
pubmed-meshheading:16026361-Blood Glucose,
pubmed-meshheading:16026361-Body Mass Index,
pubmed-meshheading:16026361-Diabetes Mellitus, Type 2,
pubmed-meshheading:16026361-Drug Therapy, Combination,
pubmed-meshheading:16026361-Fasting,
pubmed-meshheading:16026361-Female,
pubmed-meshheading:16026361-Hemoglobin A, Glycosylated,
pubmed-meshheading:16026361-Humans,
pubmed-meshheading:16026361-Hypoglycemic Agents,
pubmed-meshheading:16026361-Insulin,
pubmed-meshheading:16026361-Lipids,
pubmed-meshheading:16026361-Male,
pubmed-meshheading:16026361-Metformin,
pubmed-meshheading:16026361-Middle Aged,
pubmed-meshheading:16026361-Sulfonylurea Compounds,
pubmed-meshheading:16026361-Thiazolidinediones
|
pubmed:year |
2005
|
pubmed:articleTitle |
Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes.
|
pubmed:affiliation |
Department of Internal Medicine, University of Teikyo, Itabashi-ku, Tokyo, Japan. yama@med.teikyo-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|